224 results on '"Dal Pino, Beatrice"'
Search Results
2. Women and lipoprotein apheresis: another side of gender medicine
3. A therapeutic cooperation by bempedoic acid and proprotein convertase subtilisin/kexin type 9 inhibitors in statin intolerance inherited dyslipidemias
4. Male fertility and high cholesterol: to treat or not to treat?
5. PCSK9 and leptin plasma levels in anorexia nervosa
6. Pitavastatin for cardiovascular health in patients with HIV infection
7. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study
8. Major cardiovascular events increase in long-term proprotein convertase subtilisin/kexin type 9 inhibitors therapy: the Tuscany cost-effective study
9. A place for bempedoic acid: an effective therapeutic cooperation
10. Pitavastatin for cardiovascular health in patients with HIV infection
11. PCSK9 and leptin plasma levels in anorexia nervosa.
12. Lipoprotein (a): epidemiology, pathophysiology, measurement issues and clinical management.
13. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study
14. Comorbidity in lipoprotein apheresis: Their role in the era of new lipid‐lowering therapies
15. From direct oral anticoagulants shift to left atrial appendage closure after major stroke
16. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study
17. Familial LCAT deficiency and cardiovascular disease: the game is not over. A case of dramatic multivessel atherosclerosis
18. Comorbidity in lipoprotein apheresis: Their role in the era of new lipid‐lowering therapies.
19. Reader response: Low-density lipoprotein cholesterol and risk of intracerebral hemorrhage: A prospective study
20. Direct oral anticoagulants in lipoprotein apheresis: handle with care
21. Lipoprotein apheresis reduces major adverse cardiovascular event incidence in high-lipoprotein (a) subjects on proprotein convertase subtilisin/kexin type 9 inhibitor therapy
22. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia
23. Doctors and their children: the Pandora's jar of infectious diseases
24. Skin microcirculation significantly increases after lipoprotein apheresis
25. Therapeutic adherence in hyperlipidemia: When one size doesn't fit all
26. Hystrix cristata car accident induce acute coronary syndrome
27. Lipid modification induced by lipoprotein apheresis could mirrored mid-regional-pro-adrenomedullin plasma levels?
28. Alirocumab in lipoprotein apheresis: A synergy for patients with high-Lp(a)
29. Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab
30. Paradoxical effect of lipid lowering therapy in homozygous familial hypercholesterolemia: Atherosclerotic plaque calcifications and increased cardiovascular events
31. Eosinophilic granulomatosis with polyangiitis with heterozygous familial hypercholesterolemia: A tricky therapeutic approach with omalizumab and evolocumab
32. Lipoprotein apheresis improves intima media thickness regression: Evidence in the era of new lipid-lowering therapies
33. Heterozygous familial hypercholesterolemia and HIV infection: The appropriate therapeutic flow chart is still to be written?
34. Lipoprotein apheresis improves intima media thickness regression: Evidence in the era of new lipid-lowering therapies
35. Long-term compliance of lipoprotein apheresis patients. What is health-related quality of life?
36. Lipoprotein(a) apheresis restores coronary microcirculation in refractory angina
37. Therapeutic adherence in patients treated with PCSK9i: focus on skin side effects.
38. Is treating severe He FH so easy? A combined treatment between lipoprotein apheresis and PCSK9 inhibitors
39. Acute coronary syndrome and lipid-lowering therapy in a realistic diagnostic-therapeutic care pathway
40. Lipoprotein(a) in familial hypercholesterolemia: Tips from family history
41. Patients with diabetes mellitus and atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants
42. Adverse events and humoral response after two doses of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) mRNA vaccine in the hospital personnel of a cardiopulmonary tertiary-care center
43. A place for bempedoic acid: an effective therapeutic cooperation
44. Valor diagnóstico de la reserva de flujo coronario mediante eco-dipiridamol en la hipercolesterolemia homocigota familiar
45. Diagnostic value of coronary flow reserve determined by echo dipyridamole stress in homozygous familial hypercholesterolemia
46. Null receptor homozygous familial hypercholesterolaemia: Quoad valetudinem long life treatment
47. HeFH in real life, how to: More evolocumab than authorized
48. HDL: The ‘new’ target of cardiovascular medicine
49. Comment on “Homozygous familial hypercholesterolemia with severe involvement of the aortic valve: A sibling‐controlled case study on the efficacy of lipoprotein apheresis”
50. Achilles tendon xeroradiography in familial hypercholesterolemia: old tool for new questions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.